ALIGOS THERAPEUTICS INC (CA)
Registration and award facts
SAM.gov registration as of
- Net obligations since FY2023
- $11.29M
- $11,286,393under this UEI
- FY2026 obligations
- $0†
- Provisional
- Awards and orders
- 1
- with positive net obligations
- Latest action
- Jun 18, 2025
- SAM.gov registration
- Active
- Registration expiration date Feb 17, 2027
Registration
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Business start date
- Feb 5, 2019 (7 years)
- Location
- South San Francisco, CA
- State of incorporation
- Delaware
- Website
- aligos.com
† FY2026 obligations (provisional; DoD awards signed after Jul 26, 2026 are not yet public).
Source: SAM.gov entity registration and FPDS contract actions recorded under UEI ED19ABDRLV29. GovChime does not check exclusions.
Performance
Net obligations recorded under this UEI since FY2023. Top lists show the largest five by share of this vendor's net obligations; the shares do not sum to 100%.
Net obligations by fiscal year of action
- FY2025: $1,516,140
- FY2024: $1,300,776
- FY2023: $8,469,477
Total across 3 fiscal years: $11,286,393
Top awarding agencies
- Department of Health and Human Services$11,286,393, 100%
Top awarding sub-agencies
- National Institutes of Health$11,286,393, 100%
Top NAICS by obligations
Top product and service codes by obligations
- AN12Health r&d services; health care services; applied research$11,286,393, 100%
Capabilities
NAICS codes
Small: small business for that NAICS, self-certified in SAM.gov registration.
SBA certifications
No certification in the SBA profile data.
Product and service codes (PSC)
- AN11HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
- AN12HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
- AN21HEALTH R&D SERVICES; HEALTH RESEARCH AND TRAINING; BASIC RESEARCH
- AN22HEALTH R&D SERVICES; HEALTH RESEARCH AND TRAINING; APPLIED RESEARCH
- B599SPECIAL STUDIES/ANALYSIS- OTHER
Federal Capability Statement
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company founded with the mission to improve patient outcomes by developing best-in-class therapies for the treatment of liver and viral diseases. Aligos applies its science driven approach and deep R&D expertise to advance its purpose-built pipeline of therapeutics for diseases with high unmet medical need such as chronic hepatitis B infection (CHB), metabolic dysfunction-associated steatohepatitis (MASH), and coronaviruses.
Capabilities & Services
Contracts
Latest awards and orders
- 75N93023C00052Definitive contractDepartment of Health and Human ServicesNational Institutes of HealthLatest action
Contact Info
As of . Source: SAM.gov Points of Contact.
SAM.gov registration for ALIGOS THERAPEUTICS INC lists a physical address and a separate mailing address, along with 2 verified points of contact. Past Performance contacts are the recommended outreach channel for due-diligence references; Government Business contacts handle procurement-facing correspondence.
Source: SAM.gov entity registration. Contacts displaying numeric or placeholder names have been filtered (defense-in-depth).
Physical Address
2ND FLOOR
1, CORPORATE DRIVE
SOUTH SAN FRANCISCO, CA, 94080
USA
Mailing Address
1 CORPORATE DR FL 2
SOUTH SAN FRANCISCO, CA, 94080
USA
Government Business Contact
LESLEY CALHOUN
CHIEF FINANCIAL OFFICER
1 CORPORATE DR.
SOUTH SAN FRANCISCO, CA, 94080
USA
Government Business Alternate Contact
LESLEY CALHOUN
CHIEF FINANCIAL OFFICER
1 CORPORATE DR.
SOUTH SAN FRANCISCO, CA, 94080
USA
Additional Details
As of . Source: SAM.gov Entity Registration.
ALIGOS THERAPEUTICS INC has no active federal suspension or debarment on record in SAM.gov. Current SAM.gov registration expires February 17, 2027.
Source: SAM.gov entity registration (FAR responses, registration status). Always verify active exclusions against the authoritative record on SAM.gov before contract award.
Compliance & Risk Assessment
Source: SAM.gov FAR responsesSuspension/Debarment Status
SAM.gov registration reports no active exclusion
Public Display
Entity information is publicly displayed
Disaster Relief Registry
Registered for disaster relief contracting — Nationwide
Bonding Information
No bonding information provided
EDI
Not declared in SAM.gov
Business Structure
Source: SAM.govRegistration Details
Source: SAM.govInitial Registration
Last Update
Registration Activation
Fiscal Year End
Country of Incorporation
Congressional District
Other contractors in California with primary NAICS 541714
- Mapp Biopharmaceutical, Inc.San Diego, CA
- Terasaki Institute for Biomedical InnovationWoodland Hills, CA
- Gigagen IncSan Carlos, CA
- LA Jolla Institute for ImmunologyLa Jolla, CA
- Dnanexus, Inc.Mountain View, CA
- Hopo Therapeutics, Inc.Emeryville, CA